Evidence map›Paper›PMID 24891511›Full record

ArticleThe Journal of biological chemistry2014

Endoplasmic reticulum-associated degradation of Niemann-Pick C1: evidence for the role of heat shock proteins and identification of lysine residues that accept ubiquitin.

Naoe Nakasone, Yuko S Nakamura, Katsumi Higaki, Nao Oumi, Kousaku Ohno, Haruaki Ninomiya

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 68 citations in OpenAlex.

  1. Trial
  2. NPC1 trafficking via VPS41-dependent LAMP carriers regulates endosomal cholesterol homeostasis.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  3. Article
  4. Unifying biology of neurodegeneration in lysosomal storage diseases.Journal of inherited metabolic disease · 2025
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Understanding and Treating Niemann-Pick Type C Disease: Models Matter.International journal of molecular sciences · 2020
    Review
  12. Observational
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Naoe NakasoneFrom the Departments of Biological Regulations and.
Yuko S NakamuraApplied Biotechnology, Tottori Institute of Industrial Technology, Yonago 684-0041.
Katsumi Higakithe Division of Functional Genomics, Research Center for Bioscience and Technology, Tottori University, Yonago 683-8503, and.
Nao Oumithe Tottori University Hospital Cancer Center, Yonago 683-8504, Japan.
Kousaku OhnoChild Neurology, Tottori University Faculty of Medicine, Yonago 683-8503.
Haruaki NinomiyaFrom the Departments of Biological Regulations and ninomiya@med.tottori-u.ac.jp.
Tottori University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Most cases with Niemann-Pick disease type C carry mutations in NPC1. Some of the mutations, including the most frequent I1061T, give rise to unstable proteins selected for endoplasmic reticulum-associated degradation. The purpose of the current study was to shed mechanistic insights into the degradation process. A proteasome inhibitor MG132 prolonged the life span of the wild-type NPC1 expressed in COS cells. The expressed protein associated with multiple chaperones including heat shock protein 90 (Hsp90), Hsp70, heat shock cognate protein 70 (Hsc70), and calnexin. Accordingly, expression of an E3 ligase CHIP (carboxyl terminus of Hsp70-interacting protein) enhanced MG132-induced accumulation of ubiquitylated NPC1. Co-expression and RNAi knockdown experiments in HEK cells indicated that Hsp70/Hsp90 stabilized NPC1, whereas Hsc70 destabilized it. In human fibroblasts carrying the I1061T mutation, adenovirus-mediated expression of Hsp70 or treatment with an HSP-inducer geranylgeranylacetone (GGA) increased the level of the mutant protein. In GGA-treated cells, the rescued protein was localized in the late endosome and ameliorated cholesterol accumulation. MALDI-TOF mass spectrometry revealed three lysine residues at amino acids 318, 792, and 1180 as potential ubiquitin-conjugation sites. Substitutions of the three residues with alanine yielded a mutant protein with a steady-state level more than three times higher than that of the wild-type. Introduction of the same substitutions to the I1061T mutant resulted in an increase in its protein level and functional restoration. These findings indicated the role of HSPs in quality control of NPC1 and revealed the role of three lysine residues as ubiquitin-conjugation sites.

Indexed as

Amino Acid SubstitutionAnimalsChlorocebus aethiopsCOS CellsCysteine Proteinase InhibitorsGene Knockdown TechniquesHEK293 CellsHSC70 Heat-Shock ProteinsHSP90 Heat-Shock ProteinsHumansLeupeptinsMembrane ProteinsMembrane Transport ProteinsMutation, MissenseNiemann-Pick DiseasesTerpenesbenzyloxycarbonylleucyl-leucyl-leucine aldehydeCysteine Proteinase InhibitorsgeranylacetoneHSC70 Heat-Shock ProteinsHSP90 Heat-Shock ProteinsHSPA8 protein, humanLeupeptinsMembrane ProteinsMembrane Transport ProteinsNPC1L1 protein, humanTerpenesUbiquitinChaperoneCholesterolER-associated DegradationHeat Shock Protein (HSP)Niemann-Pick C1Ubiquitin

Identifiers

PMID24891511
PMCPMC4094081
OpenAlexW1971805725

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.